AstraZeneca’s Andexxa May Continue Dangling In Accelerated Approval After Mixed Advisory Panel

 
• By Sarah Karlin-Smith
  
Three sets of legs dangling off platform overlooking mountains
The advisory committee outcome may leave AstraZeneca's Andexxa dangling in accelerated approval. (Shutterstock)

More from US Advisory Committees

More from United States